-
Je něco špatně v tomto záznamu ?
The dynamic changes of zinc transporter 8 autoantibodies in Czech children from the onset of Type 1 diabetes mellitus
L. Petruzelkova, R. Ananieva-Jordanova, J. Vcelakova, Z. Vesely, K. Stechova, J. Lebl, P. Dusatkova, Z. Sumnik, R. Coles, M. Powell, J. Furmaniak, B. Rees Smith, S. Kolouskova,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
23952619
DOI
10.1111/dme.12308
Knihovny.cz E-zdroje
- MeSH
- autoprotilátky krev MeSH
- časové faktory MeSH
- diabetes mellitus 1. typu krev epidemiologie imunologie MeSH
- dítě MeSH
- kojenec MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- předškolní dítě MeSH
- proteiny přenášející kationty imunologie MeSH
- průřezové studie MeSH
- séroepidemiologické studie MeSH
- studie případů a kontrol MeSH
- věk při počátku nemoci MeSH
- Check Tag
- dítě MeSH
- kojenec MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- předškolní dítě MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Česká republika MeSH
AIMS: The prevalence of autoantibodies to zinc transporter 8 (ZnT8) in Czech children at the onset of Type 1 diabetes mellitus and dynamic changes in ZnT8 autoantibody levels during disease progression were studied. The value of ZnT8 autoantibody measurements in diagnosis of Type 1 diabetes was assessed. METHODS: Serum samples from 227 children with newly diagnosed Type 1 diabetes and from 101 control children without diabetes were analysed in a retrospective cross-sectional study. One hundred and seventy-one samples from 116 of the patients with diabetes were analysed in a follow-up study at (median) intervals of 1, 3, 5 and 10 years after onset of Type 1 diabetes. ZnT8 autoantibodies were measured using a bridging enzyme-linked immunosorbent assay, while antibodies to glutamic acid decarboxylase, insulinoma antigen 2 and insulin were measured by radioimmunoassays. RESULTS: ZnT8 autoantibodies were detected in 163/227 (72%) of children at Type 1 diabetes onset and in 1/101 (1%) of the control subjects. Sixteen out of 227 (7%) patients with Type 1 diabetes were antibody negative based on three antibodies (glutamic acid decarboxylase, insulinoma antigen 2 and insulin). This false-negative rate was reduced to 10/227 (4.4%) (P < 0.05) after inclusion of ZnT8 autoantibody measurements. Of the children, 142/227 (63%) were positive for at least three antibodies and the most common combination was insulinoma antigen 2, glutamic acid decarboxylase and ZnT8. ZnT8 autoantibody levels decreased over time after Type 1 diabetes onset and the presence and level of ZnT8 autoantibodies correlated with IA-2 autoantibodies. CONCLUSIONS: A ZnT8 autoantibody enzyme-linked immunosorbent assay showed 72% disease sensitivity and 99% specificity at Type 1 diabetes onset. Measurements of ZnT8 autoantibodies are important for Type 1 diabetes diagnosis and should be included in the panel of autoantibodies tested at the onset of Type 1 diabetes.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15023638
- 003
- CZ-PrNML
- 005
- 20150730111858.0
- 007
- ta
- 008
- 150709s2014 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/dme.12308 $2 doi
- 035 __
- $a (PubMed)23952619
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Petruzelkova, L $u Department of Paediatrics, University Hospital Motol and 2nd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
- 245 14
- $a The dynamic changes of zinc transporter 8 autoantibodies in Czech children from the onset of Type 1 diabetes mellitus / $c L. Petruzelkova, R. Ananieva-Jordanova, J. Vcelakova, Z. Vesely, K. Stechova, J. Lebl, P. Dusatkova, Z. Sumnik, R. Coles, M. Powell, J. Furmaniak, B. Rees Smith, S. Kolouskova,
- 520 9_
- $a AIMS: The prevalence of autoantibodies to zinc transporter 8 (ZnT8) in Czech children at the onset of Type 1 diabetes mellitus and dynamic changes in ZnT8 autoantibody levels during disease progression were studied. The value of ZnT8 autoantibody measurements in diagnosis of Type 1 diabetes was assessed. METHODS: Serum samples from 227 children with newly diagnosed Type 1 diabetes and from 101 control children without diabetes were analysed in a retrospective cross-sectional study. One hundred and seventy-one samples from 116 of the patients with diabetes were analysed in a follow-up study at (median) intervals of 1, 3, 5 and 10 years after onset of Type 1 diabetes. ZnT8 autoantibodies were measured using a bridging enzyme-linked immunosorbent assay, while antibodies to glutamic acid decarboxylase, insulinoma antigen 2 and insulin were measured by radioimmunoassays. RESULTS: ZnT8 autoantibodies were detected in 163/227 (72%) of children at Type 1 diabetes onset and in 1/101 (1%) of the control subjects. Sixteen out of 227 (7%) patients with Type 1 diabetes were antibody negative based on three antibodies (glutamic acid decarboxylase, insulinoma antigen 2 and insulin). This false-negative rate was reduced to 10/227 (4.4%) (P < 0.05) after inclusion of ZnT8 autoantibody measurements. Of the children, 142/227 (63%) were positive for at least three antibodies and the most common combination was insulinoma antigen 2, glutamic acid decarboxylase and ZnT8. ZnT8 autoantibody levels decreased over time after Type 1 diabetes onset and the presence and level of ZnT8 autoantibodies correlated with IA-2 autoantibodies. CONCLUSIONS: A ZnT8 autoantibody enzyme-linked immunosorbent assay showed 72% disease sensitivity and 99% specificity at Type 1 diabetes onset. Measurements of ZnT8 autoantibodies are important for Type 1 diabetes diagnosis and should be included in the panel of autoantibodies tested at the onset of Type 1 diabetes.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a věk při počátku nemoci $7 D017668
- 650 _2
- $a autoprotilátky $x krev $7 D001323
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 _2
- $a proteiny přenášející kationty $x imunologie $7 D027682
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a předškolní dítě $7 D002675
- 650 _2
- $a průřezové studie $7 D003430
- 650 _2
- $a diabetes mellitus 1. typu $x krev $x epidemiologie $x imunologie $7 D003922
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a kojenec $7 D007223
- 650 _2
- $a séroepidemiologické studie $7 D016036
- 650 _2
- $a časové faktory $7 D013997
- 650 _2
- $a mladý dospělý $7 D055815
- 651 _2
- $a Česká republika $x epidemiologie $7 D018153
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Ananieva-Jordanova, R $7 gn_A_00005844
- 700 1_
- $a Vcelakova, J
- 700 1_
- $a Vesely, Z
- 700 1_
- $a Stechova, K
- 700 1_
- $a Lebl, J
- 700 1_
- $a Dusatkova, P
- 700 1_
- $a Sumnik, Z
- 700 1_
- $a Coles, R
- 700 1_
- $a Powell, M
- 700 1_
- $a Furmaniak, J
- 700 1_
- $a Rees Smith, B
- 700 1_
- $a Kolouskova, S
- 773 0_
- $w MED00001389 $t Diabetic medicine a journal of the British Diabetic Association $x 1464-5491 $g Roč. 31, č. 2 (2014), s. 165-71
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/23952619 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150709 $b ABA008
- 991 __
- $a 20150730111946 $b ABA008
- 999 __
- $a ok $b bmc $g 1083975 $s 906631
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 31 $c 2 $d 165-71 $i 1464-5491 $m Diabetic medicine $n Diabet Med $x MED00001389
- LZP __
- $a Pubmed-20150709